Literature DB >> 33090388

LINC00665 facilitates the progression of osteosarcoma via sponging miR-3619-5p.

D-W Zhang1, G-Q Gu, X-Y Chen, G-C Zha, Z Yuan, Y Wu.   

Abstract

OBJECTIVE: Long non-coding RNAs (lncRNAs) play vital roles in the pathogenesis and development of multiple cancers, including osteosarcoma (OS). The present study aims to investigate the role of LINC00665 in OS progression. PATIENTS AND METHODS: The expression levels of LINC00665 and miR-3619 were assessed by RT-qPCR. The correlation between LINC00665 and miR-3619 expression was evaluated by Pearson's correlation analysis. The interaction between LINC00665 and miR-3619 was predicted by starBase, which was further confirmed by Luciferase reporter assay and RIP assay. The viability, invasion, and migration of OS cells were analyzed by CCK-8 and transwell assays.
RESULTS: LINC00665 expression was upregulated in OS tissues and cell lines, and the high level of LINC00665 was associated with poor prognosis in OS. Moreover, LINC00665 knockdown attenuated the viability, invasion, and migration of OS cells. In addition, miR-3619 was demonstrated to be a target of LINC00665. Overexpression of miR-3619 inhibited OS progression, while this effect was abolished by the upregulation of LINC00665.
CONCLUSIONS: We demonstrated that LINC 00665 accelerated OS development by targeting miR-3619. These findings might provide potential treatment strategies for patients with OS.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33090388     DOI: 10.26355/eurrev_202010_23195

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

Review 1.  Prognostic and clinicopathological values of LINC00665 in cancers: a systematic review and China population-based meta-analysis.

Authors:  Ze Jin; Ya-Jun Meng; Yu-Shuang Xu; Meng-Meng Wang; Di Chen; Xin Jiang; Zhi-Fan Xiong
Journal:  Clin Exp Med       Date:  2022-10-11       Impact factor: 5.057

2.  MicroRNA-122-3p plays as the target of long non-coding RNA LINC00665 in repressing the progress of arthritis.

Authors:  Zhiyan Wang; Qijun Tian; Yumei Tian; Zhonghua Zheng
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 3.  The Biological and Molecular Function of LINC00665 in Human Cancers.

Authors:  Cheng Zhang; Shu-Ning Xu; Ke Li; Jing-Hong Chen; Qun Li; Ying Liu
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

Review 4.  LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics.

Authors:  Chenming Zhong; Zijun Xie; Jinze Shen; Yunhua Jia; Shiwei Duan
Journal:  Cells       Date:  2022-05-04       Impact factor: 7.666

Review 5.  The Emerging Roles of LINC00665 in Human Cancers.

Authors:  Jing Zhu; Yirao Zhang; Xuyu Chen; Yibo Bian; Juan Li; Keming Wang
Journal:  Front Cell Dev Biol       Date:  2022-03-09

6.  Mechanism Analysis of LINC00665 and Its Peptides CIP2A-BP in Hepatocellular Carcinoma.

Authors:  Yi-Ran Li; Rui-Qing Zong; Hong-Yan Zhang; Xiao-Yan Meng; Fei-Xiang Wu
Journal:  Front Genet       Date:  2022-03-08       Impact factor: 4.599

7.  Silencing LINC00665 inhibits cutaneous melanoma in vitro progression and induces apoptosis via the miR-339-3p/TUBB.

Authors:  Yi Liu; Shanshan Ma; Qichao Ma; Haigang Zhu
Journal:  J Clin Lab Anal       Date:  2022-08-05       Impact factor: 3.124

8.  The Long Noncoding RNA LINC00665 Facilitates c-Myc Transcriptional Activity via the miR-195-5p MYCBP Axis to Promote Progression of Lung Adenocarcinoma.

Authors:  Anpeng Wang; Te Zhang; Wei Wei; Hui Wang; Zeyu Zhang; Wenming Yang; Wenjie Xia; Qixing Mao; Lin Xu; Feng Jiang; Gaochao Dong
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.